Department of Membrane Biochemistry and Biophysics, Utrecht University, Utrecht 3584 CH, The Netherlands.
Antibiotics (Basel). 2016 Aug 26;5(3):28. doi: 10.3390/antibiotics5030028.
Peptidoglycan is the major component of the cell envelope of virtually all bacteria. It has structural roles and acts as a selective sieve for molecules from the outer environment. Peptidoglycan synthesis is therefore one of the most important biogenesis pathways in bacteria and has been studied extensively over the last twenty years. The pathway starts in the cytoplasm, continues in the cytoplasmic membrane and finishes in the periplasmic space, where the precursor is polymerized into the peptidoglycan layer. A number of proteins involved in this pathway, such as the Mur enzymes and the penicillin binding proteins (PBPs), have been studied and regarded as good targets for antibiotics. The present review focuses on the membrane steps of peptidoglycan synthesis that involve two enzymes, MraY and MurG, the inhibitors of these enzymes and the inhibition mechanisms. We also discuss the challenges of targeting these two cytoplasmic membrane (associated) proteins in bacterial cells and the perspectives on how to overcome the issues.
肽聚糖是几乎所有细菌的细胞包膜的主要成分。它具有结构作用,并作为外部环境分子的选择性筛子。因此,肽聚糖合成是细菌中最重要的生物发生途径之一,在过去的二十年中得到了广泛的研究。该途径始于细胞质,在细胞质膜中继续,并在周质空间中完成,在前体在那里聚合到肽聚糖层中。许多参与该途径的蛋白质,如 Mur 酶和青霉素结合蛋白(PBPs),已经被研究并被认为是抗生素的良好靶点。本综述重点介绍涉及两种酶(MraY 和 MurG)的肽聚糖合成的膜步骤、这些酶的抑制剂以及抑制机制。我们还讨论了在细菌细胞中靶向这两种细胞质膜(相关)蛋白的挑战,以及如何克服这些问题的观点。